New online! Therapeutic targets for metabolic dysfunction-associated steatohepatitis: a personalized approach to disease management https://t.co/eIPEDvCIhf
Agree! Emad has been an awesome EIC! Thank you Emad for your leadership and great work. Looking forward to the incoming editors. The team looks amazing.
Words cannot really express how sad I am that @emadelomar is retiring - an absolute legend and someone I hugely admire not just as an EIC but as a person. Emad is simply the best! Looking forward to working with Bill, Matias and Thomas (BMT) - I am sure they will be amazing
Exciting news! "Clinical and Molecular Hepatology" has achieved a 2024 Impact Factor of 16.9, ranking 6th out of 143 in Gastrenterology & Hepatology.
Thank you all for your continued support and contributions. Let’s continue this journey together by advancing knowledge and driving impactful research!
#ResearchCommunity #ImpactFactor #CMH #KASL
Avances en la enfermedad conocida como hígado graso.
Científicos del @CONICETDialoga y de UMAI identifican una proteína que asocia la esteatosis hepática, conocida como hígado graso, con complicaciones en órganos vitales. @SSookoian@ValeriaRoman@EduPeriodista@norabar
Hoy, en la Academia Nacional de Medicina le entregamos el Doctorado Honoris Causa a Luis Acero, prestigioso médico español especialista en Cirugía Buco Maxilofacial. Participaron de esta ceremonia el Dr. Eduardo Rey, Adrián Giacchino, Lino Barañao, Tomás Ameigeiras y @SSookoian
Never underestimate the gut microbiome's potential impact.
New @NatureMedicine
A younger metabolic age gut microbiome counters cardiovascular risk in older adults
https://t.co/SEdEQqOg3a